SEARCH

SEARCH BY CITATION

References

  • Akasaka, T., Tanaka, M., Yamaguchi, A. and Sato, K. (2001) Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 45, 22632268.
  • Aubert, D., Poirel, L., Chevalier, J., Leotard, S., Pages, J.M. and Nordmann, P. (2001) Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45, 16151620.
  • Chen, J., Su, Z., Liu, Y., Wang, S., Dai, X., Li, Y., Peng, S., Shao, Q. et al. (2009) Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang, China. Int J Infect Dis 13, 717721.
  • Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals; approved standard, 3rd edn. In CLSI Document M31-A3. ed. Watts, J.L., Shryock, T.R., Apley, M., Bade, D.J., Brown, S.D., Gray, J.T., Heine, H., Hunter, R.P. et al. , pp. 3235. Wayne, PA: Clinical and Laboratory Standards Institute.
  • Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. In CLSI Document M100-S21 ed. Cockerill, F.R., Wikler, M.A., Bush, K., Dudley, M.N., Eliopoulos, G.M., Hardy, D.J., Hecht, D.W., Hindler, J.A. et al. , pp. 6061. Wayne, PA: Clinical and Laboratory Standards Institute.
  • Fonseca, E.L., Vieira, V.V., Cipriano, R. and Vicente, A.C. (2005) Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil. FEMS Immunol Med Microbiol 44, 303309.
  • Gu, B., Tong, M., Zhao, W., Liu, G., Ning, M. and Pan, S. (2007) Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol 45, 241243.
  • Hancock, R.E. (1998) Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27(Suppl 1), S93S99.
  • Hariharan, H., Coles, M., Poole, D., Lund, L. and Page, R. (2006) Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa. Can Vet J 47, 253255.
  • Hillier, A., Alcorn, J.R., Cole, L.K. and Kowalski, J.J. (2006) Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 cases. Vet Dermatol 17, 432439.
  • Kadlec, K. and Schwarz, S. (2008) Analysis and distribution of class 1 and class 2 integrons and associated gene cassettes among Escherichia coli isolates from swine, horses, cats and dogs collected in the BfT-GermVet monitoring study. J Antimicrob Chemother 62, 469473.
  • Ledbetter, E.C., Hendricks, L.M., Riis, R.C. and Scarlett, J.M. (2007) In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis. Am J Vet Res 68, 638642.
  • Li, X.Z., Zhang, L. and Poole, K. (2000) Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 45, 433436.
  • Linder, J.A., Huang, E.S., Steinman, M.A., Gonzales, R. and Stafford, R.S. (2005) Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118, 259268.
  • Livermore, D.M. (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34, 634640.
  • Lu, L., Dai, L., Wang, Y., Wu, C., Chen, X., Li, L., Qi, Y., Xia, L. et al. (2010) Characterization of antimicrobial resistance and integrons among Escherichia coli isolated from animal farms in Eastern China. Acta Trop 113, 2025.
  • van Mansfeld, R., Jongerden, I., Bootsma, M., Buiting, A., Bonten, M. and Willems, R. (2010) The population genetics of Pseudomonas aeruginosa isolates from different patient populations exhibits high-level host specificity. PLoS ONE 5, e13482.
  • Mazel, D., Dychinco, B., Webb, V.A. and Davies, J. (2000) Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother 44, 15681574.
  • Mekic, S., Matanovic, K. and Seol, B. (2011) Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa. Vet Rec 169, 125.
  • Mouneimne, H., Robert, J., Jarlier, V. and Cambau, E. (1999) Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 43, 6266.
  • Nikaido, H. (1994) Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382388.
  • Pellegrini, C., Mercuri, P.S., Celenza, G., Galleni, M., Segatore, B., Sacchetti, E., Volpe, R., Amicosante, G. et al. (2009) Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location. J Antimicrob Chemother 63, 901908.
  • Petersen, A.D., Walker, R.D., Bowman, M.M., Schott, H.C. II and Rosser, E.J. Jr (2002) Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 38, 407413.
  • Rubin, J., Walker, R.D., Blickenstaff, K., Bodeis-Jones, S. and Zhao, S. (2008) Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Vet Microbiol 131, 164172.
  • Sanchez-Martinez, G., Garza-Ramos, U.J., Reyna-Flores, F.L., Gaytan-Martinez, J., Lorenzo-Bautista, I.G. and Silva-Sanchez, J. (2010) In169, a new class 1 integron that encoded bla(IMP-18) in a multidrug-resistant Pseudomonas aeruginosa isolate from Mexico. Arch Med Res 41, 235239.
  • Sarlangue, J., Brissaud, O. and Labreze, C. (2006) Clinical features of Pseudomonas aeruginosa infections. Arch Pediatr 13(Suppl 1), S13S16.
  • Seol, B., Naglic, T., Madic, J. and Bedekovic, M. (2002) In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J Vet Med B Infect Dis Vet Public Health 49, 188192.
  • Severino, P. and Magalhaes, V.D. (2002) The role of integrons in the dissemination of antibiotic resistance among clinical isolates of Pseudomonas aeruginosa from an intensive care unit in Brazil. Res Microbiol 153, 221226.
  • Tenover, F.C. (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 34, S3S10; discussion S64-73.
  • Teresa Tejedor, M., Martin, J.L., Navia, M., Freixes, J. and Vila, J. (2003) Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Vet Microbiol 94, 295301.
  • Wu, Y., Li, H., Li, J. and Huang, Z.H. (2008) Detection of Pseudomonas aeruginosa carried a new array of gene cassettes within class 1 integron isolated from a teaching hospital in Nanjing, China. J Microbiol 46, 687691.
  • Yoo, J., Sohn, E.S., Chung, G.T., Lee, E.H., Lee, K.R., Park, Y.K. and Lee, Y.S. (2008) Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006). Diagn Microbiol Infect Dis 60, 291294.
  • Zhang, H., Shi, L., Li, L., Guo, S., Zhang, X., Yamasaki, S., Miyoshi, S. and Shinoda, S. (2004) Identification and characterization of class 1 integron resistance gene cassettes among Salmonella strains isolated from healthy humans in China. Microbiol Immunol 48, 639645.